About Median Technologies
Median Technologies is a medical imaging company that deploys proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services addressing life-threatening unmet medical needs. The company operates two main business lines: iCRO, which provides state-of-the-art medical image management and oncology clinical trial imaging services for pharmaceutical, biotech, and CRO partners globally; and eyonis®, an AI/ML Software as Medical Device (SaMD) platform currently under development for precision diagnostics in lung cancer screening and liver cancer (HCC). Through its Imaging Lab offering, Median delivers AI-powered insights and imaging biomarker discovery to accelerate drug development. The company transforms medical images into meaningful, actionable insights throughout the entire patient journey, from early-stage patient selection and predictive biomarker discovery to companion diagnostics development and routine clinical diagnosis. Median's iSee Platform and end-to-end quality processes help life sciences companies extract drug efficacy data and streamline clinical trials. The company recently received FDA 510(k) clearance for eyonis® LCS, described as the first AI tech-based detection and diagnosis device for lung cancer screening. Median Technologies is listed on Euronext Growth and serves a global customer base with major shareholders from Europe, USA, and Asia.
Mission & Story
Mission
Early diagnosis saves lives. We are helping conquer cancer by extracting invaluable clinical insights from patients' medical images.
Clinical Focus
Medical conditions and clinical areas addressed by Median Technologies.
Who It Serves
Milestones & Awards
Recent Milestones
FDA 510(k) clearance for eyonis® LCS received (first AI tech-based detection and diagnosis device for lung cancer screening). Collaboration with Tempus announced to expand eyonis® LCS access in United States. Capital increase successfully completed June 2026. Exhibiting at ASCO 2026 Annual Meeting.
Awards & Recognition
eyonis® LCS described as first AI tech-based detection and diagnosis device for lung cancer screening to receive FDA clearance
Key Partnerships
Social & Media
Follow on
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.